
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
over 27 years ago
Participating Facultyover 27 years ago
Benefits Foregone: Too Much of the Wrong and Too Little of the Rightover 27 years ago
Breast Cancer Epidemiology: An Overviewover 27 years ago
Overview of Cancer Economicsover 27 years ago
Breast Cancer Stage Cost Analysis in a Managed Care Populationover 27 years ago
Question-and-Answer Sessionover 27 years ago
Selected Abstracts


